Abstract:This paper describes an extended structure-activity relationships study of aminotetralin-piperazine-based hybrid molecules developed earlier for dopamine D2/D3 receptors. Various analogues as positional isomers have been developed where location of,the phenolic hydroxyl group has been varied on the aromatic ring. Between two catechol derivatives, compound 6e with a two methylene linker length exhibited higher affinity and selectivity for D3 over D2 receptors over compound 6f with four methylene linkers (D2/D3 = 50.6 vs 7.51 for 6e and 6f, respectively). In general, the (-)-isomer was more potent than the (+)-isomeric counterpart. Binding results indicated highest selectivity for D3 receptors in compound (-)-10 (K-i = 0.35 nM; D2/D3 = 71). In the 5-hydroxy series, highest selectivity for D3 receptors was exhibited by compound (-)-25 (K-i = 0.82 nM; D2/D3 = 31.5). Most potent compounds exhibited binding and functional affinities at the sub-nanomolar level for the D3 receptor. Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors by using tritiated spiperone as radioligand for competition studies to evaluate inhibition constants (K-i). A functional assay of selected compounds for stimulating GTP gamma S binding was carried out with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors. The functional assay results indicated partial to full agonist characteristics of test compounds. Compound (-)25 was selected further for in vivo study to evaluate its potency in producing contralateral rotations in rats with unilateral lesion in the nigrostriatal region induced by neurotoxin 6-OHDA, a Parkinsonian animal model. Compound (-)-25 at 5 mu mol/kg exhibited rotational activity that lasted beyond 12 h, whereas at a 1 mu mol/kg dose the rotations lasted beyond 8 h.

Synthesis, Preliminary Pharmacological Evaluation and Receptor Docking Studies of 10-Amino-3-methoxy-6,8,12,12a-tetrahydro-5h-thiazolo[4',5':4,5]Pyrido[2,1-a]isoquinolin-2-ols As Novel Dopamine D1 Receptor Inhibitors

Design, Synthesis and Evaluation of Benzo[a]thieno[3,2-G]quinolizines As Novel L-Spd Derivatives Possessing Dopamine D1, D2 and Serotonin 5-HT1A Multiple Action Profiles.

Synthesis and Biological Investigation of Tetrahydropyridopyrimidinone Derivatives As Potential Multireceptor Atypical Antipsychotics.

Design, Synthesis, and Biological Evaluation of Structurally Constrained Hybrid Analogues Containing Ropinirole Moiety As a Novel Class of Potent and Selective Dopamine D3 Receptor Ligands

Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands

Synthesis of 6-Substituted 1-Phenylbenzazepines and Their Dopamine D1 Receptor Activities

Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: Effect on affinity and selectivity for dopamine D3 receptor

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

Synthesis and Biological Evaluation of a Series of Multi-Target N-substituted Cyclic Imide Derivatives with Potential Antipsychotic Effect

Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.

Design, Synthesis, and Pharmacological Evaluation of Novel Tetrahydroprotoberberine Derivatives: Selective Inhibitors of Dopamine D1 Receptor

Synthesis and Biological Evaluation of New 6-Hydroxypyridazinone Benzisoxazoles: Potential Multi-Receptor-Targeting Atypical Antipsychotics

Isoquinolinone derivatives as potent CNS multi-receptor D2/5-HT1A/5-HT2A/5-HT6/5-HT7 agents: Synthesis and pharmacological evaluation

Design, Synthesis and Preliminary Bioactivity Evaluation of Bitopic Benzopyranomorpholine Analogues As Selective Dopamine D3 Receptor Ligands As Anti-Drug Addiction Therapeutic Agents

Bioisosteric Replacement of Amides with 1,2,3- Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics

Isoquinolinone Derivatives As Potent CNS Multi-Receptor D2/5-HT1A/5HT2A/5-HT6/5-HT7 Agents: Synthesis and Pharmacological Evaluation

Dopamine/serotonin receptor ligands. Part IV [1]: synthesis and pharmacology of novel 3-benzazecines and 3-benzazonines as potential 5-HT2A and dopamine receptor ligands

Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D2 3,4-dihydroquinolin-2(1H)-one Derivatives Related to Aripiprazole

Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors.

Design, Synthesis, and Biological Evaluation of 1,4-Diaryl-1,4-dihydropyrazines As Novel 11Β-Hsd1 Inhibitors.

Synthesis, Structure-Activity Relationships, and Biological Evaluation of A Series of Benzamides As Potential Multireceptor Antipsychotics